| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 19.5 | 14.1 | 10.8 |
| Other income | 0.1 | 0.0 | 0.0 |
| Total income | 19.6 | 14.1 | 10.9 |
| Profit before exceptional items & tax | 3.3 | 2.9 | 2.2 |
| Profit before tax | 3.3 | 2.9 | 2.2 |
| Net profit | 2.7 | 2.4 | 1.7 |
| Operating margin | 16.8% | 20.6% | 20.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +58.80% |
|---|---|
| Net profit, quarter on quarter | +12.50% |
| Revenue, year on year | +80.60% |
BSE results filing, BSE: 544694. Figures extracted from the filing.
Accretion Nutraveda Ltd: key numbers
- Share price
- ₹304.50
- Market cap
- ₹220.5 Cr
- Revenue (annual)
- ₹33.60 Cr
- Net profit (annual)
- ₹5.07 Cr
- P/E (TTM)
- 43.5×Sector 47.4×
- Promoter holding
- 73.48%+0.00% QoQ
- FII holding
- 1.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Accretion Nutraveda Ltd
All →Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited issued a Notice of Postal Ballot to seek shareholder approval for the alteration of its Memorandum of Association. Voting concludes on October 9, 2026.
Accretion Nutraveda Board Meeting Outcome
Accretion Nutraveda's board approved altering its Object Clause to include nutraceuticals and hospitals. The board also proposed increasing borrowing limits and advancing loans to related entities.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited held its 5th Annual General Meeting on 27th August, 2026, where shareholders transacted routine business, including the adoption of financial statements.
Accretion Nutraveda Other Announcement
Accretion Nutraveda Limited informed shareholders of the weblink to access the FY 2025-26 Annual Report and notice for the 5th Annual General Meeting.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited has issued notice for its 5th Annual General Meeting scheduled for August 27, 2026. The meeting will address financial statement adoption and director-related resolutions.
Accretion Nutraveda Annual Report
Accretion Nutraveda Ltd submitted its Annual Report for FY 2025-26. The company also scheduled its 5th Annual General Meeting for August 27, 2026.